Octreotide
90 Topics Found
Drug Index
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1...
I'm supposed to be taking Octreotide inj's. three times a day. How many hours should I wait in between the inj's.? ## That would be every 8 hours, if those are your prescriber's instructions. The FDA lists the typical side effects as possibly including administration site irritation, blurred vision, constipation, dry mouth, and dry skin. Are you on any other medications?
1 REPLY
Filed under
Octreotide
Octreotide Acetate
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1...
Octreotide Acetate
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1...
Octreotide
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1...
Octreotide Acetate
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1...
Drug Index
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2. Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for s...
Lanreotide
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2. Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for s...
why can't you quit taking octreotide once you start taking it? What is carcinoid crisis?
Filed under Octreotide
NDC Database
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp. ## Package Codes: 0641-6174-10 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp. ## Package Codes: 0641-6175-10 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp. ## Package Codes: 0641-6176-10 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp. ## Package Codes: 0641-6177-01 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp. ## Package Codes: 0641-6178-01 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc ## Package Codes: 0703-3301-04 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc ## Package Codes: 0703-3311-04 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc. ## Package Codes: 0703-3321-04, 0703-3321-94 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc ## Package Codes: 0703-3333-01 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc ## Package Codes: 0703-3343-01 ## Active Ingredients: Octreotide Acetate
NDC Database
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc ## Package Codes: 0781-3164-75 ## Active Ingredients: Octreotide Acetate